Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Medical Ikkou Group Co., Ltd. (JP:3353)

:3353

3353

Medical Ikkou Group Co., Ltd.

RESEARCH TOOLSreports

Medical Ikkou Group Co., Ltd. (3353) Ratios

Compare

1 Followers

Medical Ikkou Group Co., Ltd. Ratios

JP:3353's free cash flow for Q2 2025 was ¥0.12. For the 2025 fiscal year, JP:3353's free cash flow was decreased by ¥ and operating cash flow was ¥0.02. See a summary of the company’s cash flow.

Ratios	TTM	Feb 25	Feb 24	Feb 23	Feb 22
Liquidity Ratios
Current Ratio	1.53	1.54	1.61	1.78	1.73
Quick Ratio	1.34	1.35	1.44	1.61	1.59
Cash Ratio	0.57	0.58	0.74	0.86	0.95
Solvency Ratio	0.09	0.10	0.10	0.11	0.10
Operating Cash Flow Ratio	0.00	0.10	0.41	0.18	0.13
Short-Term Operating Cash Flow Coverage	0.00	0.31	1.16	0.46	0.30
Net Current Asset Value	¥ -2.43B	¥ -1.55B	¥ -1.10B	¥ -1.66B	¥ -2.59B
Leverage Ratios
Debt-to-Assets Ratio	0.30	0.29	0.30	0.33	0.39
Debt-to-Equity Ratio	0.75	0.71	0.72	0.76	0.99
Debt-to-Capital Ratio	0.43	0.42	0.42	0.43	0.50
Long-Term Debt-to-Capital Ratio	0.33	0.30	0.30	0.33	0.39
Financial Leverage Ratio	2.54	2.43	2.39	2.28	2.56
Debt Service Coverage Ratio	0.46	0.44	0.51	0.57	0.47
Interest Coverage Ratio	18.38	26.50	28.86	18.41	21.90
Debt to Market Cap	1.00	1.19	1.06	0.92	1.16
Interest Debt Per Share	2.97K	2.69K	2.56K	2.44K	3.03K
Net Debt to EBITDA	1.46	1.33	0.75	1.21	1.38
Profitability Margins
Gross Profit Margin	11.58%	11.58%	11.41%	9.39%	10.76%
EBIT Margin	3.17%	3.50%	4.30%	4.03%	4.57%
EBITDA Margin	4.71%	5.07%	6.27%	6.51%	7.16%
Operating Profit Margin	3.17%	3.50%	3.91%	2.76%	3.80%
Pretax Profit Margin	3.42%	3.93%	4.17%	3.88%	4.39%
Net Profit Margin	1.99%	2.34%	2.61%	2.24%	2.54%
Continuous Operations Profit Margin	2.03%	2.37%	2.71%	2.28%	2.59%
Net Income Per EBT	58.36%	59.59%	62.54%	57.82%	57.73%
EBT Per EBIT	107.84%	112.39%	106.63%	140.48%	115.72%
Return on Assets (ROA)	2.87%	3.31%	3.28%	2.76%	2.93%
Return on Equity (ROE)	7.47%	8.04%	7.85%	6.30%	7.49%
Return on Capital Employed (ROCE)	6.94%	7.50%	7.34%	4.66%	6.17%
Return on Invested Capital (ROIC)	3.57%	3.87%	4.07%	2.40%	3.08%
Return on Tangible Assets	2.95%	3.41%	3.38%	2.92%	3.11%
Earnings Yield	9.87%	13.70%	11.67%	7.81%	8.90%
Efficiency Ratios
Receivables Turnover	6.58	6.47	6.59	6.77	6.87
Payables Turnover	7.04	7.05	7.22	8.93	8.61
Inventory Turnover	19.87	19.31	20.17	25.01	24.70
Fixed Asset Turnover	4.96	4.82	4.38	3.54	3.41
Asset Turnover	1.44	1.41	1.26	1.23	1.15
Working Capital Turnover Ratio	7.43	7.67	6.59	5.68	6.27
Cash Conversion Cycle	22.06	23.52	22.94	27.64	25.50
Days of Sales Outstanding	55.51	56.41	55.41	53.91	53.11
Days of Inventory Outstanding	18.37	18.90	18.10	14.60	14.78
Days of Payables Outstanding	51.82	51.80	50.57	40.87	42.38
Operating Cycle	73.87	75.32	73.51	68.51	67.89
Cash Flow Ratios
Operating Cash Flow Per Share	0.00	318.70	1.14K	348.08	302.19
Free Cash Flow Per Share	0.00	53.54	1.05K	255.58	212.46
CapEx Per Share	0.00	265.16	86.24	92.49	89.73
Free Cash Flow to Operating Cash Flow	0.00	0.17	0.92	0.73	0.70
Dividend Paid and CapEx Coverage Ratio	0.00	1.01	9.02	2.63	2.33
Capital Expenditure Coverage Ratio	0.00	1.20	13.20	3.76	3.37
Operating Cash Flow Coverage Ratio	0.00	0.12	0.45	0.14	0.10
Operating Cash Flow to Sales Ratio	0.00	0.02	0.11	0.04	0.03
Free Cash Flow Yield	0.00%	2.43%	44.37%	9.87%	8.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	10.13	7.30	8.57	12.80	11.24
Price-to-Sales (P/S) Ratio	0.20	0.17	0.22	0.29	0.29
Price-to-Book (P/B) Ratio	0.74	0.59	0.67	0.81	0.84
Price-to-Free Cash Flow (P/FCF) Ratio	0.00	41.09	2.25	10.13	12.00
Price-to-Operating Cash Flow Ratio	0.00	6.90	2.08	7.44	8.44
Price-to-Earnings Growth (PEG) Ratio	-10.91	0.82	0.23	-1.18	4.43
Price-to-Fair Value	0.74	0.59	0.67	0.81	0.84
Enterprise Value Multiple	5.75	4.70	4.31	5.62	5.36
Enterprise Value	14.67B	11.55B	10.79B	12.40B	12.90B
EV to EBITDA	5.75	4.70	4.31	5.62	5.36
EV to Sales	0.27	0.24	0.27	0.37	0.38
EV to Free Cash Flow	0.00	57.36	2.73	12.92	16.16
EV to Operating Cash Flow	0.00	9.64	2.52	9.48	11.36
Tangible Book Value Per Share	3.85K	3.65K	3.45K	2.96K	2.72K
Shareholders’ Equity Per Share	3.93K	3.75K	3.52K	3.21K	3.03K
Tax and Other Ratios
Effective Tax Rate	0.41	0.40	0.35	0.41	0.41
Revenue Per Share	14.38K	12.87K	10.62K	9.02K	8.94K
Net Income Per Share	286.98	301.35	276.71	202.20	226.92
Tax Burden	0.58	0.60	0.63	0.58	0.58
Interest Burden	1.08	1.12	0.97	0.96	0.96
Research & Development to Revenue	0.00	0.00	0.00	0.00	0.00
SG&A to Revenue	<0.01	<0.01	<0.01	<0.01	<0.01
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.00	1.06	2.57	1.00	0.77

Currency in JPY